CVE-2020-27269

In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications lacks replay protection measures, which allows unauthenticated, physically proximate attackers to replay communication sequences via Bluetooth Low Energy.

CVSS v3 5.7 MEDIUM
CVSS v2.0 2.9 LOW

5.7^/10

CVSS v3 : MEDIUM

Vector :

Exploitability : 2.1 / Impact : 3.6

Attack Vector ADJACENT_NETWORK

Attack Complexity LOW

Privileges Required NONE

User Interaction REQUIRED

Confidentiality Impact HIGH

Integrity Impact NONE

Availability Impact NONE

Scope UNCHANGED

2.9^/10

CVSS v2.0 : LOW

Vector : AV:A/AC:M/Au:N/C:P/I:N/A:N

Exploitability : 5.5 / Impact : 2.9

Access Vector ADJACENT_NETWORK

Access Complexity MEDIUM

Authentication NONE

Confidentiality Impact PARTIAL

Integrity Impact NONE

Availability Impact NONE

References

Link	Resource
https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01	Third Party Advisory US Government Resource
https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01	Third Party Advisory US Government Resource

Configurations

Configuration 1 (hide)

AND

cpe:2.3:o:sooil:anydana-a_firmware:*:*:*:*:*:*:*:*

cpe:2.3:h:sooil:anydana-a:-:*:*:*:*:*:*:*

Configuration 2 (hide)

AND

cpe:2.3:o:sooil:anydana-i_firmware:*:*:*:*:*:*:*:*

cpe:2.3:h:sooil:anydana-i:-:*:*:*:*:*:*:*

Configuration 3 (hide)

AND

cpe:2.3:o:sooil:diabecare_rs_firmware:*:*:*:*:*:*:*:*

cpe:2.3:h:sooil:diabecare_rs:-:*:*:*:*:*:*:*

History

21 Nov 2024, 05:20

Type	Values Removed	Values Added
References	~~() https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01 - Third Party Advisory, US Government Resource~~	() https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01 - Third Party Advisory, US Government Resource

Information

Published : 2021-01-19 22:15

Updated : 2024-11-21 05:20

NVD link : CVE-2020-27269

Mitre link : CVE-2020-27269

CVE.ORG link : CVE-2020-27269

JSON object : View

Products Affected

sooil

anydana-i
anydana-a
anydana-a_firmware
diabecare_rs_firmware
anydana-i_firmware
diabecare_rs

CWE

CWE-294

Authentication Bypass by Capture-replay

{"id": "CVE-2020-27269", "metrics": {"cvssMetricV2": [{"type": "Primary", "source": "nvd@nist.gov", "cvssData": {"version": "2.0", "baseScore": 2.9, "accessVector": "ADJACENT_NETWORK", "vectorString": "AV:A/AC:M/Au:N/C:P/I:N/A:N", "authentication": "NONE", "integrityImpact": "NONE", "accessComplexity": "MEDIUM", "availabilityImpact": "NONE", "confidentialityImpact": "PARTIAL"}, "acInsufInfo": false, "impactScore": 2.9, "baseSeverity": "LOW", "obtainAllPrivilege": false, "exploitabilityScore": 5.5, "obtainUserPrivilege": false, "obtainOtherPrivilege": false, "userInteractionRequired": true}], "cvssMetricV31": [{"type": "Primary", "source": "nvd@nist.gov", "cvssData": {"scope": "UNCHANGED", "version": "3.1", "baseScore": 5.7, "attackVector": "ADJACENT_NETWORK", "baseSeverity": "MEDIUM", "vectorString": "CVSS:3.1/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N", "integrityImpact": "NONE", "userInteraction": "REQUIRED", "attackComplexity": "LOW", "availabilityImpact": "NONE", "privilegesRequired": "NONE", "confidentialityImpact": "HIGH"}, "impactScore": 3.6, "exploitabilityScore": 2.1}]}, "published": "2021-01-19T22:15:12.487", "references": [{"url": "https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01", "tags": ["Third Party Advisory", "US Government Resource"], "source": "ics-cert@hq.dhs.gov"}, {"url": "https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01", "tags": ["Third Party Advisory", "US Government Resource"], "source": "af854a3a-2127-422b-91ae-364da2661108"}], "vulnStatus": "Modified", "weaknesses": [{"type": "Secondary", "source": "ics-cert@hq.dhs.gov", "description": [{"lang": "en", "value": "CWE-294"}]}, {"type": "Primary", "source": "nvd@nist.gov", "description": [{"lang": "en", "value": "CWE-294"}]}], "descriptions": [{"lang": "en", "value": "In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications lacks replay protection measures, which allows unauthenticated, physically proximate attackers to replay communication sequences via Bluetooth Low Energy."}, {"lang": "es", "value": "En SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i y AnyDana-A, el protocolo de comunicaci\u00f3n de la bomba de insulina y sus aplicaciones m\u00f3viles AnyDana-i y AnyDana-A, carece de medidas de protecci\u00f3n de reproducci\u00f3n, lo que permite a los atacantes no autenticados f\u00edsicamente pr\u00f3ximos poder reproducir secuencias de comunicaci\u00f3n por medio de Bluetooth Low Energy"}], "lastModified": "2024-11-21T05:20:58.480", "configurations": [{"nodes": [{"negate": false, "cpeMatch": [{"criteria": "cpe:2.3:o:sooil:anydana-a_firmware:*:*:*:*:*:*:*:*", "vulnerable": true, "matchCriteriaId": "808DBA89-C2C2-4C03-814D-DB0B4DFF8B22", "versionEndExcluding": "3.0"}], "operator": "OR"}, {"negate": false, "cpeMatch": [{"criteria": "cpe:2.3:h:sooil:anydana-a:-:*:*:*:*:*:*:*", "vulnerable": false, "matchCriteriaId": "2624582E-762F-4CDB-B974-1BC971F1544D"}], "operator": "OR"}], "operator": "AND"}, {"nodes": [{"negate": false, "cpeMatch": [{"criteria": "cpe:2.3:o:sooil:anydana-i_firmware:*:*:*:*:*:*:*:*", "vulnerable": true, "matchCriteriaId": "98E25B7D-C1ED-4144-8411-171C7B6426E4", "versionEndExcluding": "3.0"}], "operator": "OR"}, {"negate": false, "cpeMatch": [{"criteria": "cpe:2.3:h:sooil:anydana-i:-:*:*:*:*:*:*:*", "vulnerable": false, "matchCriteriaId": "E25CB863-07D9-4E90-8022-6C2B4C52EDFC"}], "operator": "OR"}], "operator": "AND"}, {"nodes": [{"negate": false, "cpeMatch": [{"criteria": "cpe:2.3:o:sooil:diabecare_rs_firmware:*:*:*:*:*:*:*:*", "vulnerable": true, "matchCriteriaId": "C5C154F1-7F29-4EC0-9971-76A02C6DA8BC", "versionEndExcluding": "3.0"}], "operator": "OR"}, {"negate": false, "cpeMatch": [{"criteria": "cpe:2.3:h:sooil:diabecare_rs:-:*:*:*:*:*:*:*", "vulnerable": false, "matchCriteriaId": "8628A530-AF34-453E-968A-40DD5B8EE456"}], "operator": "OR"}], "operator": "AND"}], "sourceIdentifier": "ics-cert@hq.dhs.gov"}